Toronto - Free Realtime Quote CAD

Curaleaf Holdings, Inc. (CURA.TO)

1.2100
+0.0100
+(0.83%)
As of 11:34:19 AM EDT. Market Open.
Loading Chart for CURA.TO
  • Previous Close 1.2000
  • Open 1.2000
  • Bid 1.2100 x --
  • Ask 1.2200 x --
  • Day's Range 1.2000 - 1.2400
  • 52 Week Range 1.0050 - 8.1950
  • Volume 82,547
  • Avg. Volume 410,195
  • Market Cap (intraday) 913.196M
  • Beta (5Y Monthly) 1.14
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4300
  • Earnings Date May 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 4.20

Curaleaf Holdings, Inc. produces and distributes cannabis products in the United States and internationally. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. It also provides hemp-based products and cannabinoids, such as cannabidiol and cannabigerol. In addition, the company engages in the cultivation, production, and sale of hemp-derived THC products through wholesale channels. The company is headquartered in Stamford, Connecticut.

www.curaleaf.com

5,519

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CURA.TO

View More

Performance Overview: CURA.TO

Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CURA.TO
43.72%
S&P/TSX Composite index (^GSPTSE)
2.03%

1-Year Return

CURA.TO
83.45%
S&P/TSX Composite index (^GSPTSE)
12.70%

3-Year Return

CURA.TO
84.24%
S&P/TSX Composite index (^GSPTSE)
21.75%

5-Year Return

CURA.TO
93.60%
S&P/TSX Composite index (^GSPTSE)
69.35%

Compare To: CURA.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CURA.TO

View More

Valuation Measures

As of 5/6/2025
  • Market Cap

    905.65M

  • Enterprise Value

    1.96B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.48

  • Price/Book (mrq)

    0.76

  • Enterprise Value/Revenue

    1.05

  • Enterprise Value/EBITDA

    6.07

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -16.04%

  • Return on Assets (ttm)

    0.42%

  • Return on Equity (ttm)

    -19.98%

  • Revenue (ttm)

    1.34B

  • Net Income Avi to Common (ttm)

    -232.38M

  • Diluted EPS (ttm)

    -0.4300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    107.23M

  • Total Debt/Equity (mrq)

    106.98%

  • Levered Free Cash Flow (ttm)

    -40.93M

Research Analysis: CURA.TO

View More

People Also Watch